Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood–brain barrier into brain

References

• Abbott NJ. (2005). Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25:5–23.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Ajazuddin, Tripathi DK, et al. (2017). Recent advancements in liposomes targeting strategies to cross blood–brain barrier (BBB) for the treatment of Alzheimer's disease. J Control Release 260:61–77.
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. (2013). Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:102.
   PubMed Web of Science ®Google Scholar
• Alavijeh MS, Chishty M, Qaiser MZ, et al. (2005). Drug metabolism and pharmacokinetics, the blood–brain barrier, and central nervous system drug discovery. Neurotherapeutics 2:554–71.
   Google Scholar
• Ballabh P, Braun A, Nedergaard M. (2004). The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1–13.
   PubMed Web of Science ®Google Scholar
• Basu S, Mukherjee B, Chowdhury SR, et al. (2012). Colloidal gold-loaded, biodegradable, polymer-based stavudine nanoparticle uptake by macrophages: an in vitro study. Int J Nanomedicine 7:6049–61.
   PubMed Web of Science ®Google Scholar
• Bergshoeff AS, Fraaij PLA, Verweij C, et al. (2004). Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children. J Antimicrob Chemother 54:1152–4.
   PubMed Web of Science ®Google Scholar
• Blum MR, Liao SH, Good SS, Miranda P. (1988). Pharmacokinetics and bioavailability of zidovudine in humans. Am J Med 85:189–94.
   PubMed Web of Science ®Google Scholar
• Carnielli VP, Verlato G, Pederzini F, et al. (1998). Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Am J Clin Nutr 67:97–103.
   PubMed Web of Science ®Google Scholar
• Christoper GVP, Raghavan CV, Siddharth K, et al. (2014). Formulation and optimization of coated PLGA – zidovudine nanoparticles using factorial design and in vitro in vivo evaluations to determine brain targeting efficiency. Saudi Pharm J 22:133–40.
   PubMed Web of Science ®Google Scholar
• Cole L, Coleman J, Evans D, Hawes C. (1990). Internalisation of fluorescein isothiocyanate and fluorescein isothiocyanate-dextran by suspension-cultured plant cells. J Cell Sci 96:721–30.
   Web of Science ®Google Scholar
• Das PJ, Paul P, Mukherjee B, et al. (2015). Pulmonary delivery of voriconazole loaded nanoparticles providing a prolonged drug level in lungs: a promise for treating fungal infection. Mol Pharm 12:2651–64.
   PubMed Web of Science ®Google Scholar
• Dawson DA, Wadsworth G, Palmer AM. (2001). A comparative assessment of the efficacy and side effect liability of neuroprotective compounds in experimental stroke. Brain Res 892:344–50.
   PubMed Web of Science ®Google Scholar
• Dey NS, Mukherjee B, Maji R, Satapathy BS. (2016). Development of linker-conjugated nanosize lipid vesicles: a strategy for cell selective treatment in breast cancer. Curr Cancer Drug Targets 16:357–72.
   PubMed Web of Science ®Google Scholar
• Fox CB, Mulligan SK, Sung J, et al. (2014). Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes. Int J Nanomedicine 9:1367–77.
   PubMed Web of Science ®Google Scholar
• Gautam N, Bathena SPR, Chen Q, et al. (2013). Pharmacokinetics, protein binding, and metabolism of a quinoxaline urea analog as a NF-кB inhibitor in mice and rats by LC–MS/MS. Biomed Chromatogr 27:900–9.
   PubMed Web of Science ®Google Scholar
• Gharib A, Faezizadeh Z, Namin SARM, Saravani R. (2014). Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin. Daru 22:44.
   PubMed Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, et al. (2009). Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release 134:55–61.
   PubMed Web of Science ®Google Scholar
• Hu X, Yang F, Liao Y, et al. (2017). Cholesterol-PEG comodified poly (N-butyl) cyanoacrylate nanoparticles for brain delivery: in vitro and in vivo evaluations. Drug Deliv 24:121–32.
   PubMed Web of Science ®Google Scholar
• Ivey NS, MacLean AG, Lackner AA. (2009). Acquired immunodeficiency syndrome and the blood–brain barrier. J Neurovirol 15:111–22.
   PubMed Web of Science ®Google Scholar
• Jain S, Tiwary AK, Jain NK. (2008). PEGylated elastic liposomal formulation for lymphatic targeting of zidovudine. Curr Drug Deliv 5:275–81.
   PubMedGoogle Scholar
• Jones ML. (2008). Lipids. In: Bancroft JD, Gamble M, eds. Theory and practice of histological techniques. Philadelphia: Churchill Livingstone Elsevier, 187–216.
   Google Scholar
• Kittiphoom S. (2012). Utilization of mango seed. Int Food Res J 19:1325–35.
   Google Scholar
• Klein CJ. (2002). Nutrient requirements for preterm infant formulas. J Nutr 132:1395S–577S.
   PubMed Web of Science ®Google Scholar
• Li X, Tsibouklis J, Weng T, et al. (2017). Nano carriers for drug transport across the blood–brain barrier. J Drug Target 25:17–28.
   PubMed Web of Science ®Google Scholar
• Maji R, Dey NS, Satapathy BS, et al. (2014). Preparation and characterization of tamoxifen citrate loaded nanoparticles for breast cancer therapy. Int J Nanomedicine 9:3107–18.
   PubMed Web of Science ®Google Scholar
• Mandal TK, Tenjarla S. (1996). Preparation of biodegradable microcapsules of zidovudine using solvent evaporation: effect of the modification of aqueous phase. Int J Pharm 137:187–97.
   Web of Science ®Google Scholar
• Martins S, Tho I, Reimold I, et al. (2012). Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm 439:49–62.
   PubMed Web of Science ®Google Scholar
• Masarudin MJ, Cutts SM, Evison BJ, et al. (2015). Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnol Sci Appl 8:67–80.
   PubMed Web of Science ®Google Scholar
• Masserini M. (2013). Nanoparticles for brain drug delivery. ISRN Biochem 2013:1–18.
   Google Scholar
• Mu L, Zhou R, Tang F, et al. (2016). Intracellular pharmacokinetic study of zidovudine and its phosphorylated metabolites. Acta Pharm Sin B 6:158–62.
   PubMed Web of Science ®Google Scholar
• Nath B, Nath LK, Kumar P. (2011). Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations. Acta Pol Pharm 68:409–15.
   PubMed Web of Science ®Google Scholar
• Nayak UY, Gopal S, Mutalik S, et al. (2009). Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine. J Microencapsul 26:214–22.
   PubMed Web of Science ®Google Scholar
• Oh SY, Jeong SY, Park TG, Lee JH. (1998). Enhanced transdermal delivery of AZT (zidovudine) using iontophoresis and penetration enhancer. J Control Release 51:161–8.
   PubMed Web of Science ®Google Scholar
• Pattnaik G, Sinha B, Mukherjee B, et al. (2012). Submicron-size biodegradable polymer-based didanosine particles for treating HIV at early stage: an in vitro study. J Microencapsul 29:666–76.
   PubMed Web of Science ®Google Scholar
• Rautio J, Laine K, Gynther M, Savolainen J. (2008). Prodrug approaches for CNS delivery. AAPS J 10:92–102.
   PubMed Web of Science ®Google Scholar
• Rudra A, Deepa RM, Ghosh MK, et al. (2010). Doxorubicin-loaded phosphatidylethanolamine-conjugated nanoliposomes: in vitro characterization and their accumulation in liver, kidneys, and lungs in rats. Int J Nanomedicine 5:811–23.
   PubMed Web of Science ®Google Scholar
• Sahana B, Santra K, Basu S, Mukherjee B. (2010). Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation. Int J Nanomedicine 5:621–30.
   PubMed Web of Science ®Google Scholar
• Satapathy BS, Mukherjee B, Baishya R, et al. (2016). Lipid nanocarrier-based transport of docetaxel across the blood brain barrier. RSC Adv 6:85261–74.
   Web of Science ®Google Scholar
• Seju U, Kumar A, Sawant KK. (2011). Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater 7:4169–76.
   PubMed Web of Science ®Google Scholar
• Shaw TK, Mandal D, Dey G, et al. (2017). Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor. Drug Deliv 24:346–57.
   PubMed Web of Science ®Google Scholar
• Singh S, Dobhal AK, Jain A, et al. (2010). Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine. Chem Pharm Bull 58:650.
   PubMed Web of Science ®Google Scholar
• Takasato Y, Rapoport SI, Smith QR. (1984). An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 247:H484–93.
   PubMed Web of Science ®Google Scholar
• Thomas NS, Panchagnula R. (2003). Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Eur J Pharm Sci 18:71–9.
   PubMed Web of Science ®Google Scholar
• Tripathi KM, Castro M, Feller JF, Sankar SK. (2017). Characterization of metal, semiconductor, and metal-semiconductor core–shell nanostructures. In: Gupta RK, Misra M, eds. Metal Semiconductor Core–Shell Nanostructures for Energy and Environmental Applications. Netherlands: Elsevier, 51–78.
   Google Scholar
• Vieira DB, Gamarra LF. (2016). Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. Int J Nanomedicine 11:5381–414.
   PubMed Web of Science ®Google Scholar
• Weiss N, Miller F, Cazaubon S, Couraud PO. (2009). The blood–brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788:842–57.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. (2008). Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles. Eur J Pharm Biopharm 70:75–84.
   PubMed Web of Science ®Google Scholar